BIOLASE to Present at Benchmark Discovery One-on-One Virtual Investor Conference on December 2, 2021
FOOTHILL RANCH, California, 23 November 2021 / PRNewswire / – BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will be presenting at the Benchmark Company Discovery One-on-One Virtual Investor Conference on Thursday 2 December, 2021.
Event: One-to-one virtual investor conference on the discovery of the benchmark company
Dated: Thursday 2 December 2021
Time: 8h00 – 4:30 p.m. EST
Available for one-on-one meetings
To schedule a one-to-one meeting or for more information, please contact the Benchmark Company conference coordinators at [emailÂ protected] or BIOLASE’s investor relations company, EVC Group, LLC.
About the benchmark company discovery conference
The Benchmark Company Annual Discovery Conference is hosted by The Benchmark Company, a boutique investment bank based in new York, with regional offices across the country. Benchmark provides research, sales, trading and investment banking services to public and private companies, institutional and high net worth investors and family offices. The conference is attended regularly by over 150 institutional investors and will feature approximately 50 presenting companies.
About BIOLASE, Inc.
BIOLASE is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. BIOLASE products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE’s proprietary laser products incorporate approximately 271 patented technologies and 40 patent pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE’s innovative products offer cutting-edge technology at competitive prices to deliver superior results to dentists and patients. BIOLASE’s main products are revolutionary dental laser systems that perform a wide range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold more than 41,200 laser systems to date in more than 80 countries around the world. Laser products under development address BIOLASE’s core dental market and other adjoining medical and consumer applications.
For updates and information on Waterlase iPlusÂ®, Waterlase Express â¢ and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter on www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.
BIOLASEÂ®, WaterlaseÂ® and Waterlase iPlusÂ® are registered trademarks of BIOLASE, Inc.
SOURCE BIOLASE, Inc.